martes, 1 de diciembre de 2015

National Guideline Clearinghouse | Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

FULL-TEXT ►

National Guideline Clearinghouse | Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.



American Academy of Pediatrics

National Guideline Clearinghouse (NGC)

Guideline Title
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.
Bibliographic Source(s)
Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, Phelan KJ, Zorc JJ, Stanko-Lopp D, Brown MA, Nathanson I, Rosenblum E, Sayles S III, Hernandez-Cancio S, American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014 Nov;134(5):e1474-502. [242 references] PubMed External Web Site Policy
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006 Oct;118(4):1774-93. [166 references].
All clinical practice guidelines from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.
This guideline meets NGC's 2013 (revised) inclusion criteria.
.-.-.-.



Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. - PubMed - NCBI



 2014 Nov;134(5):e1474-502. doi: 10.1542/peds.2014-2742.

Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Abstract

This guideline is a revision of the clinical practice guideline, "Diagnosis and Management of Bronchiolitis," published by the American Academy of Pediatrics in 2006. The guideline applies to children from 1 through 23 months of age. Other exclusions are noted. Each key action statement indicates level of evidence, benefit-harm relationship, and level of recommendation. Key action statements are as follows:
Copyright © 2014 by the American Academy of Pediatrics.

KEYWORDS:

bronchiolitis; children; evidence-based; guideline; infants; respiratory syncytial virus

PMID:
 
25349312
 
[PubMed - indexed for MEDLINE] 
Free full text

No hay comentarios:

Publicar un comentario